Highest-materiality recent filing
Dr. Erica Schwartz to resign as director if confirmed as CDC Director; nominated by President Trump April 16, 2026.
Butterfly Network Q1 revenue $26.5M (+25% YoY) beats consensus; reaffirms FY guidance
Q1 revenue $26.5M (+25% YoY); gross margin 68.9% (up 600 bps YoY).
Record quarterly revenue of $31.5M, up 41% YoY; Midjourney partnership contributed $6.8M in Q4.
NYSE to delist Butterfly Network warrants (BFLY WS) due to abnormally low selling price
NYSE notified Butterfly Network on Jan 13, 2026, to delist its warrants (BFLY WS) and suspend trading immediately due to 'abnormally low selling price' per Section 802.01D.
Butterfly Network expects Q4 2025 revenue growth of at least 17% YoY
Preliminary Q4 2025 revenue growth of at least 17% year over year.
Exclusive license to Midjourney for Butterfly's semiconductor-based ultrasound technology in a specified field of use.
Revenue $21.5M, up 5% YoY from $20.6M; adjusted gross margin 63.9% vs 60.0% prior year.
Butterfly Network appoints John Doherty as CFO effective Dec 8, 2025
John Doherty, former CFO of Kaltura and Magic Leap, named EVP, CFO of Butterfly Network, effective Dec 8, 2025.
Butterfly Q2 revenue $23.4M (+9% YoY), record gross margins, CFO resigns
Q2 revenue $23.4M (+9% YoY); gross margin 63.7% vs 58.6% prior year; record quarterly highs.
All seven director nominees elected with over 99% of votes cast; Joseph DeVivo led with 619,242,104 votes for.
Butterfly Network Q1 revenue $21.2M (+20% YoY); net loss reduced 36%; reiterates FY guidance
Revenue $21.2M (+20% YoY); U.S. revenue $16.6M (+24%) driven by iQ3 probe and partner chip sales.
Butterfly Network Q4 revenue up 35% to $22.4M; net loss down 59%; guides FY2025 revenue $96-100M
Q4 revenue $22.4M (+35% YoY); product revenue $14.7M (+45%); software revenue $7.6M (+20%).
Butterfly Network prices public offering of 24M shares at $3.15, raising ~$75.6M
Offering of 24,000,000 shares of Class A common stock at $3.15 per share; underwriters have 30-day option for additional 3,600,000 shares.
Butterfly reports preliminary cash ~$92.8M; launches public stock offering
Preliminary cash, cash equivalents, and restricted cash of ~$92.8M at Dec 31, 2024 (unaudited, subject to change).
Butterfly Network reports preliminary Q4 2024 revenue growth of ~35% YoY
Preliminary unaudited Q4 2024 revenue growth approximately 35% year over year.
Butterfly Network Q3 revenue $20.6M (+33% YoY), raises FY 2024 guidance
Q3 revenue $20.6M (+33% YoY); net loss improved 38% to $16.9M; adjusted EBITDA loss $8.4M.
Butterfly Network Q2 revenue $21.5M (record), net loss down 45%, raises EBITDA guidance
Record quarterly revenue of $21.5M, up 16% YoY; product revenue $14.6M (+19%) and software $6.8M (+10%).
Stockholders approve 2024 ESPP and charter amendments at annual meeting
All seven director nominees re-elected with >95% votes in favor.
Q1 revenue $17.7M, up 14% YoY; net loss narrowed to $21.8M from $33.5M.
On May 4, 2026, Dr. Erica Schwartz notified the Board of Directors (the “Board”) of Butterfly Network, Inc. (the “Company”) that she will resign as a director of the Company subject to and effective upon her confirmation as Director of the Centers for Disease Control and Prevention (the “CDC”) by the U.S. Senate.
On May 7, 2026, the Board appointed Caroll H. Neubauer to the Board, effective on May 18, 2026 (the “Effective Date”).
Max materiality 0.85 · Median 0.70 · Most common event earnings